Mutations in the JAK2 and MPL Genes and their Correlation to Clinical Parameters in Patients with Chronic Myeloproliferative Disease

Publisher： Karger

E-ISSN： 2296-5262|32|4|191-195

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.4, 2009-03, pp. : 191-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

JAK2 and MPL Mutations in Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-10 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis

By  

Acta Haematologica, Vol. 124, Iss. 3, 2010-10 ,pp. : 160-161

Karger

Access to resources Recommend Favorite

Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2V617F Mutation Status

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-04 ,pp. : 54-62

Karger

Access to resources Recommend Favorite